Enovis (ENOV) Earnings Analysis
Enovis (ENOV) next reports earnings on 2026-08-06, consensus EPS 0.83 USD. Last quarter (2026-05-07) it beat with EPS 0.89 USD vs 0.82 USD est (+8.5%). It has beaten estimates in 6/6 recent quarters (100%). Trailing P/E -1.33.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ENOV next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | 0.83 USD |
| Revenue estimate | 0.58B |
ENOV earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | 0.89 USD | 0.82 USD | +8.5% | Beat |
| 2026-02-26 | 0.95 USD | 0.81 USD | +17.3% | Beat |
| 2025-11-06 | 0.75 USD | 0.67 USD | +11.9% | Beat |
| 2025-08-07 | 0.79 USD | 0.74 USD | +6.8% | Beat |
| 2025-05-08 | 0.81 USD | 0.74 USD | +9.5% | Beat |
| 2025-02-26 | 0.98 USD | 0.92 USD | +6.5% | Beat |
Beat rate: 6/6 (100%) over reported quarters with consensus data.
ENOV valuation and analyst view
| Trailing P/E | -1.33 |
|---|---|
| Trailing EPS | -20.02462 USD |
| Price / book | 1.02 |
| Dividend yield | 0.00% |
| Market cap | 1.52B |
| Analyst consensus | Buy (10 buy / 3 hold / 0 sell) |
| Avg price target | 32.33 USD |
Related research pages
Frequently asked questions
When is Enovis (ENOV)'s next earnings date?
Enovis is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 0.83 USD and revenue estimate of 0.58B.
Did ENOV beat earnings last quarter?
In its 2026-05-07 report, ENOV posted EPS of 0.89 USD versus a 0.82 USD estimate — a beat of 8.5%.
What is ENOV's earnings track record?
Over the last 6 reported quarters with consensus data, ENOV beat estimates 6 times (100%).
What is ENOV's current P/E ratio and EPS?
ENOV trades at a trailing P/E of -1.33 on trailing EPS of -20.02461614311875 USD.
What do analysts rate ENOV?
Analyst consensus is "Buy" across 13 ratings (0 strong buy, 10 buy, 3 hold, 0 sell, 0 strong sell). Average 12-month price target: 32.33 USD.